We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

34 hedge funds and large institutions have $13M invested in Zosano Pharma Corporation in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

3% less funds holding

Funds holding: 35 → 34 (-1)

5% less capital invested

Capital invested by funds: $13.7M → $13M (-$713K)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.24M
2
GCP
GSA Capital Partners
United Kingdom
+$730K
3
State Street
State Street
Massachusetts
+$386K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$365K
5
VF
Virtu Financial
New York
+$138K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$353K
2
Citadel Advisors
Citadel Advisors
Florida
-$111K
3
WG
Winton Group
United Kingdom
-$80K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$52K
5
TSS
Two Sigma Securities
New York
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$10K -$7.35K -228 -44%
AAS
27
Avantax Advisory Services
Texas
$10K – – –
EC
28
Estate Counselors
Wisconsin
$4K – – –
HFM
29
Hartford Financial Management
Connecticut
$3K – – –
Wells Fargo
30
Wells Fargo
California
$2K +$1.23K +38 +200%
GRP
31
Global Retirement Partners
California
$1K – – –
WG
32
Winton Group
United Kingdom
– -$80K -1,845 Closed
Bank of New York Mellon
33
Bank of New York Mellon
New York
– -$52K -1,192 Closed
TSS
34
Two Sigma Securities
New York
– -$40K -929 Closed
TRCT
35
Tower Research Capital (TRC)
New York
– -$36K -829 Closed
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
– -$34K -786 Closed
Squarepoint
37
Squarepoint
New York
– -$23K -532 Closed
Osaic Holdings
38
Osaic Holdings
Arizona
– -$15K -343 Closed
Commonwealth Equity Services
39
Commonwealth Equity Services
Massachusetts
– -$12K -292 Closed
MWP
40
Meridian Wealth Partners
Pennsylvania
– -$1K -22 Closed
Bank of America
41
Bank of America
North Carolina
– +$32 +1 New
ASN
42
Advisory Services Network
Georgia
– +$97 +3 New
1
2

ZSAN Hedge Fund Activity: Q2 2021 in Review

34 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2021, worth a combined $13M — down 5.2% from $13.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ZSAN and 8 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.24M. The largest seller was BlackRock, cutting an estimated $353K.

  • 34 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2021, down from 35 in Q1 2021.
  • Funds reported $13M of Zosano Pharma Corporation stock for Q2 2021, down 5.2% quarter-over-quarter.
  • 8 funds opened new Zosano Pharma Corporation positions in Q2 2021 and 9 closed out, a net change of -1 holder.
  • The largest Zosano Pharma Corporation buyer in Q2 2021 was Renaissance Technologies, an estimated $1.24M added.
  • The largest Zosano Pharma Corporation seller in Q2 2021 was BlackRock, an estimated $353K sold.

Based on aggregated 13F filings for Q2 2021.